Skip to main content

System-Level Analysis of the Effects of RPTPs on Cellular Signaling Networks

  • Protocol
  • First Online:
Protein Tyrosine Phosphatases

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2743))

Abstract

Tyrosine phosphorylation regulates signaling network activity downstream of receptor tyrosine kinase (RTK) activation. Receptor protein tyrosine phosphatases (RPTPs) serve to dephosphorylate RTKs and their proximal adaptor proteins, thus serving to modulate RTK activity. While the general function of RPTPs is well understood, the direct and indirect substrates for each RPTP are poorly characterized. Here we describe a method, quantitative phosphotyrosine phosphoproteomics, that enables the identification of specific phosphorylation sites whose phosphorylation levels are altered by the expression and activity of a given RPTP. In a proof-of-concept application, we use this method to highlight several direct or indirect substrate phosphorylation sites for PTPRJ, also known as DEP1, and show their quantitative phosphorylation in the context of wild-type PTPRJ compared to a mutant form of PTPRJ with increased activity, in EGF-stimulated cells. This method is generally applicable to define the signaling network effects of each RPTP in cells or tissues under different physiological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bixby JL (2001) Ligands and signaling through receptor-type tyrosine phosphatases. IUBMB Life 51:157–163. https://doi.org/10.1080/152165401753544223

    Article  CAS  PubMed  Google Scholar 

  2. Barr AJ, Ugochukwu E, Lee WH et al (2009) Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136:352–363. https://doi.org/10.1016/J.CELL.2008.11.038

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tonks NK (2013) Protein tyrosine phosphatases - from housekeeping enzymes to master regulators of signal transduction. FEBS J 280:346–378. https://doi.org/10.1111/FEBS.12077

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7:833–846. https://doi.org/10.1038/NRM2039

    Article  CAS  PubMed  Google Scholar 

  5. Nunes-Xavier CE, Martín-Pérez J, Elson A, Pulido R (2013) Protein tyrosine phosphatases as novel targets in breast cancer therapy. Biochim Biophys Acta Rev Cancer 1836:211–226. https://doi.org/10.1016/J.BBCAN.2013.06.001

    Article  CAS  Google Scholar 

  6. Östman A, Hellberg C, Böhmer FD (2006) Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 6:307–320. https://doi.org/10.1038/NRC1837

    Article  PubMed  Google Scholar 

  7. Tarcic G, Boguslavsky SK, Wakim J et al (2009) An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol 19:1788–1798. https://doi.org/10.1016/J.CUB.2009.09.048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Xu Y, Tan LJ, Grachtchouk V et al (2005) Receptor-type protein-tyrosine phosphatase-κ regulates epidermal growth factor receptor function. J Biol Chem 280:42694–42700. https://doi.org/10.1074/jbc.M507722200

    Article  CAS  PubMed  Google Scholar 

  9. Bilwes AM, Den Hertog J, Hunter T, Noel JP (1996) Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization. Nature 382:555–559. https://doi.org/10.1038/382555A0

    Article  CAS  PubMed  Google Scholar 

  10. Bloch E, Sikorski EL, Pontoriero D et al (2019) Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes. J Biol Chem 294:18796–18806. https://doi.org/10.1074/JBC.RA119.010229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bennasroune A, Fickova M, Gardin A et al (2004) Transmembrane peptides as inhibitors of ErbB receptor signaling. Mol Biol Cell 15:3464–3474. https://doi.org/10.1091/MBC.E03-10-0753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported in part by grants from the National Institutes of Health, including U01CA238720 and R01GM139998, as well as support from the Center for Precision Cancer Medicine in the Koch Institute for Integrative Research at MIT.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Forest M. White .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Gerritsen, J., Rizzo, S., Thévenin, D., White, F.M. (2024). System-Level Analysis of the Effects of RPTPs on Cellular Signaling Networks. In: Thévenin, D., P. Müller, J. (eds) Protein Tyrosine Phosphatases. Methods in Molecular Biology, vol 2743. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3569-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3569-8_10

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3568-1

  • Online ISBN: 978-1-0716-3569-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics